Total investments in startups fell 9 percent to $6.67 billion from $7.34 billion a year ago. There were 913 deals completed in the second quarter, down 6 percent from last year's 970.
Funding for biotechnology companies and consumer products and services startups increased. The biggest category, software, saw a decline in the dollar amount invested as well as the number of deals completed.
The top deals, worth $150 million each, went to design marketplace Fab.com and biotech firm Precision for Medicine Inc.
The MoneyTree study released Friday was conducted by PriceWaterHouseCoopers and the National Venture Capital Association, based on data from Thomson Reuters.
MORE HBJ HEADLINES
Fortune 500 company will bring prestige, boost to local philanthropy New Jeep Renegade: Small stature, big character United dangles jet order to spur pilot pact Canadian employment climbs in September on part-time gains Apple Pay will expand to Starbucks, KFC, Chiliís SEC seeks oversight of Everett-based developer accused of fraud
Our new comment system is not supported in IE 7. Please upgrade your browser here.